Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
INTELLIPHARMACEU RG (NQ: IPCI)
0.4608 USD  +0.0048 (+1.05%)
Official Closing Price  /  Updated: 5:20 PM EDT, Jun 21, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 39,901
Open 0.4500
Bid (Size) 0.4500 (1000)
Ask (Size) 0.4685 (300)
Prev. Close 0.4560
Today's Range 0.4500 - 0.4746
52wk Range 0.3200 - 2.920
Shares Outstanding 43,537,849
Dividend Yield N/A
Performance
YTD
-45.24%
-45.24%
1 Month
+8.32%
+8.32%
3 Month
-25.92%
-25.92%
6 Month
-38.56%
-38.56%
1 Year
-78.47%
-78.47%
Top News
More News
Intellipharmaceutics Receives Anticipated Additional Staff Determination Letter from NASDAQ
from ACCESSWIRE
Nasdaq Hearings Panel Grants Intellipharmaceutics' Request for Continued Listing
from ACCESSWIRE
More News
Read More
Intellipharmaceutics Reports Director Election Results
from ACCESSWIRE
Intellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ER
from ACCESSWIRE
Intellipharmaceutics looking forward to 2nd half of 2018
category Intellipharmaceutics , Finance , Ipci , and 6 more.
from PRLog
Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination
from ACCESSWIRE
Intellipharmaceutics Receives Delisting Determination from NASDAQ Staff; Company to Request Hearing
from ACCESSWIRE
Intellipharmaceutics Announces First Quarter 2018 Results
from ACCESSWIRE
Intellipharmaceutics Announces Closing of US$1.8 Million Financing
from ACCESSWIRE
Intellipharmaceutics Announces US$1.8 Million Registered Direct Offering
from ACCESSWIRE
Intellipharmaceutics Announces Closing of US$3.5 Million Financing
from ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.